Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines

Stephen J Russell1, Glen N Barber2

  • 1Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Cancer Cell
|April 11, 2018
PubMed

Insights

Oncolytic viruses (OVs) selectively destroy tumors, enhancing anti-tumor immune responses. This makes OVs effective companions for cancer therapies and potential standalone treatments.

Area of Science:

  • Immunology
  • Virology
  • Oncology

Background:

  • Oncolytic viruses (OVs) selectively destroy neoplastic tissues.
  • OVs can boost neoantigen-specific cytotoxic T lymphocyte (CTL) responses.
  • OVs are considered ideal companions for checkpoint blockade therapy.

Purpose of the Study:

  • To discuss the mechanisms by which OVs modulate tumor cell adjuvanticity and antigenicity.
  • To explore the potential of OVs as standalone cancer therapies.

Main Methods:

  • Discussion of OV mechanisms in cancer therapy.
  • Analysis of immune response modulation by OVs.

Main Results:

  • OV therapy does not appear to suppress antitumor immunity.
  • Viral antigen expression diminishes as antiviral response matures, honing CTL response to tumor neoantigens.
  • OVs combine direct tumor destruction with immune system boosting.

Conclusions:

  • OVs enhance anti-tumor immunity by modulating tumor antigenicity and adjuvanticity.
  • OVs show promise as potent standalone cancer therapies.
  • OVs are valuable partners for checkpoint blockade therapy.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
51.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.4K
What are Viruses?00:50

What are Viruses?

Overview
128.4K
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
3.4K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.7K